Together, our data suggests that levels of both ST6GAL1 and larger branched α2-6 sialylated tri-antennary and tetra-antennary N-glycans remain high in prostate cancer cells after they have disseminated from the primary site and established metastatic lesions in bone. This evidence concerns the gene ST6GAL1 and Familial prostate cancer.